Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 Jul;66(1):99–105. doi: 10.1038/bjc.1992.224

Early and late changes in the normal mouse bladder reservoir function due to irradiation and cis-DDP.

F Lundbeck 1, J Overgaard 1
PMCID: PMC1977894  PMID: 1637684

Abstract

Early and late changes in the reservoir function of the mouse bladder were investigated after radiation alone or a combination of radiation and cisplatinum (cis-DDP). Bladder function was investigated by repeated cystometries. Treatments consisted of either single fraction radiation (5-10-15-25-30 Gy) or 20 Gy in combination with cis-DDP (6 mg kg-1; i.p.) administered at various time intervals from 14 days before until 14 days after radiation. At two selected time intervals (15 min and 4 h before) radiation was given at different dose levels (5-10-15-20 Gy). Within 30 days after irradiation a dose-dependent early response was noticed both in the radiation alone group and the group where cis-DDP was administered 15 min before radiation. The dose-response curve showed a slight but non-significant shift to the left in the combined treatment group (dose effect factor (DEF) = 1.18). Investigation of the early change in bladder reservoir function in the animals treated with 20 Gy alone or a combination of 20 Gy plus cis-DDP at various intervals in relation to irradiation demonstrated a significant increase in response when cis-DDP was administered 24 h and 15 min before and 4 h, 72 h and 336 h after 20 Gy (P less than 0.05). The reversible nature of the early damage was demonstrated. Late response was irreversible and significantly increased in most groups were cis-DDP was administered from 168 h before until 72 h after compared to radiation alone. Comparing groups treated with radiation alone with groups where cis-DDP was administered 15 min and 4 h before radiation revealed DEF values up to 1.45 (P less than 0.05), reflecting the significantly larger response in combined treatment groups. Survival was significantly decreased in all combined treatment groups compared to groups treated with radiation only and likewise survival was decreased in the group treated by cis-DDP alone compared to control (no treatment at all).

Full text

PDF
99

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartelink H., Kallman R. F., Rapacchietta D., Hart G. A. Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation. Radiother Oncol. 1986 May;6(1):61–74. doi: 10.1016/s0167-8140(86)80110-4. [DOI] [PubMed] [Google Scholar]
  2. Dewit L., Oussoren Y., Bartelink H. Early and late damage in the mouse rectum after irradiation and cis-diamminedichloroplatinum(II). Radiother Oncol. 1987 Jan;8(1):57–69. doi: 10.1016/s0167-8140(87)80023-3. [DOI] [PubMed] [Google Scholar]
  3. Fu K. K., Lam K. N. Early and late effects of cisplatin and radiation at acute and low dose rates on the mouse skin and soft tissues of the leg. Int J Radiat Oncol Biol Phys. 1991 Feb;20(2):327–332. doi: 10.1016/0360-3016(91)90114-j. [DOI] [PubMed] [Google Scholar]
  4. Grau C., Bentzen S. M., Overgaard J. Cytotoxic effect of misonidazole and cyclophosphamide on aerobic and hypoxic cells in a C3H mammary carcinoma in vivo. Br J Cancer. 1990 Jan;61(1):61–64. doi: 10.1038/bjc.1990.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hendry J. H., Thames H. D. The tissue-rescuing unit. Br J Radiol. 1986 Jun;59(702):628–630. doi: 10.1259/0007-1285-59-702-628. [DOI] [PubMed] [Google Scholar]
  6. Knowles J. F., Trott K. R. Experimental irradiation of the rat ureter: the effects of field size and the presence of contrast medium on incidence and latency of hydronephrosis. Radiother Oncol. 1987 Sep;10(1):59–66. doi: 10.1016/s0167-8140(87)80070-1. [DOI] [PubMed] [Google Scholar]
  7. Landuyt W., Ang K. K., van der Schueren E. Combinations of single doses and fractionated treatments of cis-dichlorodiammineplatinum (II) and irradiation: effect on mouse lip mucosa. Br J Cancer. 1986 Oct;54(4):579–586. doi: 10.1038/bjc.1986.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lelieveld P., Scoles M. A., Brown J. M., Kallman R. F. The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin. Int J Radiat Oncol Biol Phys. 1985 Jan;11(1):111–121. doi: 10.1016/0360-3016(85)90369-4. [DOI] [PubMed] [Google Scholar]
  9. Luk K. H., Ross G. Y., Phillips T. L., Goldstein L. S. The interaction of radiation and cis-diamminedichloroplatinum (II) in intestinal crypt cells. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1417–1420. doi: 10.1016/0360-3016(79)90681-3. [DOI] [PubMed] [Google Scholar]
  10. Lundbeck F., Djurhuus J. C., Vaeth M. Bladder filling in mice: an experimental in vivo model to evaluate the reservoir function of the urinary bladder in a long term study. J Urol. 1989 May;141(5):1245–1249. doi: 10.1016/s0022-5347(17)41231-6. [DOI] [PubMed] [Google Scholar]
  11. Lundbeck F., Stewart F. A. Acute changes in the bladder reservoir function after irradiation alone or in combination with chemotherapy: a matter of mouse strain. Scand J Urol Nephrol Suppl. 1989;125:141–147. [PubMed] [Google Scholar]
  12. Lundbeck F., Ulsø N., Overgaard J. Cystometric evaluation of early and late irradiation damage to the mouse urinary bladder. Radiother Oncol. 1989 Aug;15(4):383–392. doi: 10.1016/0167-8140(89)90085-6. [DOI] [PubMed] [Google Scholar]
  13. Michalowski A., Wheldon T. E., Kirk J. Can cell survival parameters be deduced from non clonogenic assays of radiation damage to normal tissues? Br J Cancer Suppl. 1984;6:257–261. [PMC free article] [PubMed] [Google Scholar]
  14. Moore D. H., Mendelsohn M. L. Optimal treatment levels in cancer therapy. Cancer. 1972 Jul;30(1):97–106. doi: 10.1002/1097-0142(197207)30:1<97::aid-cncr2820300116>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  15. Overgaard J., Khan A. R. Selective enhancement of radiation response in a C3H mammary carcinoma by cisplatin. Cancer Treat Rep. 1981 May-Jun;65(5-6):501–503. [PubMed] [Google Scholar]
  16. Overgaard J., Matsui M. Effect of radiation on glucose absorption in the mouse jejunum in vivo. Radiother Oncol. 1990 May;18(1):71–77. doi: 10.1016/0167-8140(90)90024-q. [DOI] [PubMed] [Google Scholar]
  17. Pearson A. E., Steel G. G. Chemotherapy in combination with pelvic irradiation: a time-dependence study in mice. Radiother Oncol. 1984 Jun;2(1):49–55. doi: 10.1016/s0167-8140(84)80038-9. [DOI] [PubMed] [Google Scholar]
  18. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Robbins M. E., Robinson M., Rezvani M., Golding S. J., Hopewell J. W. The response of the pig kidney to the combined effects of cisplatin and unilateral renal irradiation. Radiother Oncol. 1988 Mar;11(3):271–278. doi: 10.1016/0167-8140(88)90010-2. [DOI] [PubMed] [Google Scholar]
  20. Siddik Z. H., Boxall F. E., Harrap K. R. Haematological toxicity of carboplatin in rats. Br J Cancer. 1987 Apr;55(4):375–379. doi: 10.1038/bjc.1987.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sternberg C. N., Yagoda A., Scher H. I., Watson R. C., Herr H. W., Morse M. J., Sogani P. C., Vaughan E. D., Jr, Bander N., Weiselberg L. R. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J Urol. 1988 Mar;139(3):461–469. doi: 10.1016/s0022-5347(17)42494-3. [DOI] [PubMed] [Google Scholar]
  22. Stewart F. A., Denekamp J., Hirst D. G. Proliferation kinetics of the mouse bladder after irradiation. Cell Tissue Kinet. 1980 Jan;13(1):75–89. doi: 10.1111/j.1365-2184.1980.tb00451.x. [DOI] [PubMed] [Google Scholar]
  23. Stewart F. A., Lundbeck F., Oussoren Y., Luts A. Acute and late radiation damage in mouse bladder: a comparison of urination frequency and cystometry. Int J Radiat Oncol Biol Phys. 1991 Oct;21(5):1211–1219. doi: 10.1016/0360-3016(91)90278-c. [DOI] [PubMed] [Google Scholar]
  24. Stewart F. A., Michael B. D., Denekamp J. Late radiation damage in the mouse bladder as measured by increased urination frequency. Radiat Res. 1978 Sep;75(3):649–659. [PubMed] [Google Scholar]
  25. Stewart F. A. The proliferative and functional response of mouse bladder to treatment with radiation and cyclophosphamide. Radiother Oncol. 1985 Dec;4(4):353–362. doi: 10.1016/s0167-8140(85)80123-7. [DOI] [PubMed] [Google Scholar]
  26. Stewart F., Bohlken S., Begg A., Bartelink H. Renal damage in mice after treatment with cisplatinum alone or in combination with X-irradiation. Int J Radiat Oncol Biol Phys. 1986 Jun;12(6):927–933. doi: 10.1016/0360-3016(86)90387-1. [DOI] [PubMed] [Google Scholar]
  27. von der Maase H. Experimental studies on interactions of radiation and cancer chemotherapeutic drugs in normal tissues and a solid tumour. Radiother Oncol. 1986 Sep;7(1):47–68. doi: 10.1016/s0167-8140(86)80124-4. [DOI] [PubMed] [Google Scholar]
  28. von der Maase H. Interactions of radiation and adriamycin, bleomycin, mitomycin C or cis-diamminedichloroplatinum II in intestinal crypt cells. Br J Cancer. 1984 Jun;49(6):779–786. doi: 10.1038/bjc.1984.121. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES